Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Response Confirms Senators On Right Trail About N.Y. Herbal Product Tests

This article was originally published in The Tan Sheet

Executive Summary

“FDA does not use DNA sequencing by itself to analyze an herbal extract for phytochemicals,” Associate Commissioner for Legislation Thomas Kraus tells Senators Hatch and Heinrich. The senators gave FDA an opportunity, without asking for a comment on an ongoing New York investigation, to describe the agency’s regulation of supplement manufacturing.

You may also be interested in...

New York AG Plies Third Pact Pushing DNA Testing On Supplement Firms

NBTY notes that FDA regulations allow firms flexibility in test methodologies for ingredient identity and other testing required under the supplement GMP final rule, and industry stakeholders say compliance with the GMPs is the standard, not a state agency's preferences.

Market America Asked To Comb Records For Serious AERs About Its Supplements

An FDA inspection found two serious adverse event reports Market America received were not forwarded to the agency as required. Its response didn't answer whether it would review its records "to determine if a serious adverse event report should be submitted to FDA.”

Herbalife 'Just Getting Started' On Growth Following Flat 2019 At $4.9bn Net Sales

"We're a growth company, well-positioned in a global trend of nutrition that the world hasn't seen before," says co-president John Agwunobi. But the direct seller's record volume increase in 2019 didn’t translate to revenue growth as China, Mexico and Central and South America pulled down results.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts